---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-277420"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2021-09-20T23:59:59+00:00"
generated_at: "2026-06-29T02:45:03.395653+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks completes $15.8B SPAC merger; begins NYSE trading under DNA

## Summary
- Transaction valued at ~$15.8B; Old Ginkgo equity holders received ~49.08 New Ginkgo shares per old share.
- PIPE investment of $760M (76M shares at $10.00) raised concurrently with closing.
- Earn-out shares up to 188.7M shares vest based on stock price targets ($12.50/$15.00/$17.50/$20.00) over 5 years.
- Post-closing shares outstanding: ~1.75B Class A and B common (excluding earn-out and warrants); total ~2.01B.
- Class A common and warrants began trading on NYSE Sept 17, 2021 under symbols DNA and DNA.WS.

## SEC filing metadata
- accession: 0001193125-21-277420
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2021-09-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 9.01, 3.02, 4.01, 3.03, 8.01, 5.01, 5.02, 5.03, 5.06
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/d186750d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-277420
- JSON: https://secwatch.observer/filing/0001193125-21-277420.json
- Plain text: https://secwatch.observer/filing/0001193125-21-277420.txt

## Key facts
- Executive change
  Reshma Shetty was appointed as President and Chief Operating Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: President and Chief Operating Officer
  source text: Ms. Shetty was appointed as President and Chief Operating Officer;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Jason Kelly was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Dennis A. Miller departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Arie Belldegrun was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Mark Dmytruk was appointed as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Mark Dmytruk was appointed as Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Christian Henry was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Laurence E. Paul departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Reshma Kewalramani was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Jason Kelly was appointed as Chief Executive Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Mr. Kelly was appointed as the Company’s Chief Executive Officer;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Shyam Sankar was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Harry E. Sloan departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Harry E. Sloan was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Joshua Kazam departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Scott M. Delman departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Reshma Shetty was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Isaac Lee departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Timothy Leiweke departed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: ceased
  - Role: Director
  source text: Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
- Executive change
  Marijn Dekkers was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.